Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 8146545 | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (AFLURIA) | SEQIRUS, INC. | 1 | AX4604A | IM / RA |
Approximately 15 minutes after injection, patient presented to pharmacy with a red, raised, itching rash. RPh attempted to administer 25 mg of liquid benadryl which was refused by the patient for fear of sedation. Patient agreed to take 12. mg of liquid benadryl at 12:07 pm. Patient was monitored until 12:37 pm at which point the rash had resolved. patient was contacted via phone at 2:13 pm and reported her symptoms have resolved. RPh counseled patient to go to the ED if symptoms persist or worsen
n/a
MDD,
fluoxetine, hydroxyzine, bupropion
opioids, sulfa meds